Medtronic takes improved implantable drug pump to the US
This article was originally published in Clinica
Executive Summary
Medtronic has received US approval to sell a new version of its drug-delivering implantable pump for treating chronic pain and managing severe spasticity - stiff muscles commonly associated with neurologic diseases, such as cerebral palsy, multiple sclerosis and stroke.